• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性肝病中的铁死亡:分子机制与治疗意义

Ferroptosis in non-alcoholic liver disease: Molecular mechanisms and therapeutic implications.

作者信息

Cheng Zilu, Chu Huikuan, Zhu Qingjing, Yang Ling

机构信息

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Jinyintan Hospital, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Front Nutr. 2023 Mar 13;10:1090338. doi: 10.3389/fnut.2023.1090338. eCollection 2023.

DOI:10.3389/fnut.2023.1090338
PMID:36992907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10040549/
Abstract

Ferroptosis refers to a novel modality of regulated cell death characterized by excessive iron accumulation and overwhelming lipid peroxidation, which takes an important part in multiple pathological processes associated with cell death. Considering the crucial roles of the liver in iron and lipid metabolism and its predisposition to oxidative insults, more and more studies have been conducted to explore the relationship between ferroptosis and various liver disorders, including non-alcoholic fatty liver disease (NAFLD). With increased morbidity and high mortality rates, NAFLD has currently emerged as a global public health issue. However, the etiology of NAFLD is not fully understood. In recent years, an accumulating body of evidence have suggested that ferroptosis plays a pivotal role in the pathogenesis of NAFLD, but the precise mechanisms underlying how ferroptosis affects NAFLD still remain obscure. Here, we summarize the molecular mechanisms of ferroptosis and its complicated regulation systems, delineate the different effects that ferroptosis exerts in different stages of NAFLD, and discuss some potential effective therapies targeting ferroptosis for NAFLD treatment, which putatively points out a novel direction for NAFLD treatment.

摘要

铁死亡是一种新型的程序性细胞死亡方式,其特征是铁过量积累和脂质过氧化反应失控,在与细胞死亡相关的多种病理过程中起重要作用。鉴于肝脏在铁和脂质代谢中的关键作用及其易受氧化损伤的特性,越来越多的研究致力于探索铁死亡与包括非酒精性脂肪性肝病(NAFLD)在内的各种肝脏疾病之间的关系。随着发病率和死亡率的上升,NAFLD目前已成为一个全球性的公共卫生问题。然而,NAFLD的病因尚未完全明确。近年来,越来越多的证据表明铁死亡在NAFLD的发病机制中起关键作用,但铁死亡如何影响NAFLD的具体机制仍不清楚。在此,我们总结了铁死亡的分子机制及其复杂的调控系统,阐述了铁死亡在NAFLD不同阶段所发挥的不同作用,并讨论了一些针对铁死亡的潜在有效治疗方法用于NAFLD的治疗,这可能为NAFLD的治疗指出一个新的方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45c2/10040549/56b7c6cfacbd/fnut-10-1090338-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45c2/10040549/e024b91803f8/fnut-10-1090338-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45c2/10040549/56b7c6cfacbd/fnut-10-1090338-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45c2/10040549/e024b91803f8/fnut-10-1090338-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45c2/10040549/56b7c6cfacbd/fnut-10-1090338-g002.jpg

相似文献

1
Ferroptosis in non-alcoholic liver disease: Molecular mechanisms and therapeutic implications.非酒精性肝病中的铁死亡:分子机制与治疗意义
Front Nutr. 2023 Mar 13;10:1090338. doi: 10.3389/fnut.2023.1090338. eCollection 2023.
2
An overview of ferroptosis in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中的铁死亡概述
Biomed Pharmacother. 2022 Sep;153:113374. doi: 10.1016/j.biopha.2022.113374. Epub 2022 Jul 11.
3
Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies.铁死亡在非酒精性脂肪性肝病中的作用及其对治疗策略的启示
Biomedicines. 2021 Nov 10;9(11):1660. doi: 10.3390/biomedicines9111660.
4
Lipid Peroxidation in Ferroptosis and Association with Nonalcoholic Fatty Liver Disease.脂质过氧化在铁死亡中的作用及其与非酒精性脂肪性肝病的关系。
Front Biosci (Landmark Ed). 2023 Dec 6;28(12):332. doi: 10.31083/j.fbl2812332.
5
Unveiling the role of ferroptosis in the progression from NAFLD to NASH: recent advances in mechanistic understanding.揭示铁死亡在从非酒精性脂肪性肝病到非酒精性脂肪性肝炎进展中的作用:机制理解的最新进展。
Front Endocrinol (Lausanne). 2024 Jul 4;15:1431652. doi: 10.3389/fendo.2024.1431652. eCollection 2024.
6
Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease.针对铁稳态调节作为非酒精性脂肪性肝病潜在治疗策略的研究进展。
Metabolism. 2024 Aug;157:155953. doi: 10.1016/j.metabol.2024.155953. Epub 2024 Jun 15.
7
Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases.非酒精性脂肪性肝病中的矿物质代谢和铁死亡。
Biochem Pharmacol. 2022 Nov;205:115242. doi: 10.1016/j.bcp.2022.115242. Epub 2022 Sep 7.
8
Ferroptosis in liver disease: new insights into disease mechanisms.肝病中的铁死亡:对疾病机制的新见解
Cell Death Discov. 2021 Oct 5;7(1):276. doi: 10.1038/s41420-021-00660-4.
9
Ferroptosis as a new therapeutic opportunity for nonviral liver disease.铁死亡作为一种非病毒性肝脏疾病的新治疗机会。
Eur J Pharmacol. 2021 Oct 5;908:174319. doi: 10.1016/j.ejphar.2021.174319. Epub 2021 Jul 9.
10
The Gut Microbiome and Ferroptosis in MAFLD.非酒精性脂肪性肝病中的肠道微生物群与铁死亡
J Clin Transl Hepatol. 2023 Feb 28;11(1):174-187. doi: 10.14218/JCTH.2022.00136. Epub 2022 Jul 14.

引用本文的文献

1
Focusing on perihematomal hypoperfusion following intracerebral hemorrhage: from oxidative stress to prospective therapeutic approaches.关注脑出血后的血肿周围低灌注:从氧化应激到前瞻性治疗方法。
Front Physiol. 2025 Aug 5;16:1646959. doi: 10.3389/fphys.2025.1646959. eCollection 2025.
2
FSP1 and CoQ10 have the potential to serve as biomarkers for severe preeclampsia.FSP1和辅酶Q10有潜力作为重度子痫前期的生物标志物。
BMC Pregnancy Childbirth. 2025 Aug 6;25(1):813. doi: 10.1186/s12884-025-07930-4.
3
Mechanistic Elucidation of Polysaccharides in Treating MAFLD via Regulation of the Gut Microbiota-Metabolite-Ferroptosis Axis: A Multi-Omics Perspective.

本文引用的文献

1
Iron Status and NAFLD among European Populations: A Bidirectional Two-Sample Mendelian Randomization Study.欧洲人群的铁状态与非酒精性脂肪性肝病:一项双向两样本孟德尔随机化研究。
Nutrients. 2022 Dec 8;14(24):5237. doi: 10.3390/nu14245237.
2
Attenuation by Time-Restricted Feeding of High-Fat and High-Fructose Diet-Induced NASH in Mice Is Related to Per2 and Ferroptosis.限时喂养对高脂肪高果糖饮食诱导的 NASH 小鼠的衰减作用与 Per2 和铁死亡有关。
Oxid Med Cell Longev. 2022 Oct 15;2022:8063897. doi: 10.1155/2022/8063897. eCollection 2022.
3
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).
基于多组学视角解析多糖通过调节肠道微生物群-代谢物-铁死亡轴治疗MAFLD的机制
J Agric Food Chem. 2025 Jun 26. doi: 10.1021/acs.jafc.5c05877.
4
Ferroptosis in Gastrointestinal Diseases: A New Frontier in Pathogenesis and Therapy.胃肠道疾病中的铁死亡:发病机制与治疗的新前沿
J Clin Med. 2025 Jun 7;14(12):4035. doi: 10.3390/jcm14124035.
5
ω-6 PUFA-enriched membrane phospholipid composition of cardiomyocytes increases the susceptibility to iron-induced ferroptosis and inflammation.心肌细胞中富含ω-6多不饱和脂肪酸的膜磷脂组成增加了对铁诱导的铁死亡和炎症的易感性。
Apoptosis. 2025 May 17. doi: 10.1007/s10495-025-02121-0.
6
Life-threatening risk factors contribute to the development of diseases with the highest mortality through the induction of regulated necrotic cell death.危及生命的风险因素通过诱导程序性坏死性细胞死亡,促成了死亡率最高的疾病的发展。
Cell Death Dis. 2025 Apr 11;16(1):273. doi: 10.1038/s41419-025-07563-7.
7
Ferroptosis in NAFLD: insights and the therapeutic potential of exercise.非酒精性脂肪性肝病中的铁死亡:见解与运动的治疗潜力
Front Med (Lausanne). 2025 Mar 26;12:1462145. doi: 10.3389/fmed.2025.1462145. eCollection 2025.
8
A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Liver Disease.谷胱甘肽疗法改善非酒精性脂肪性肝病肝功能障碍的文献综述
Biomedicines. 2025 Mar 6;13(3):644. doi: 10.3390/biomedicines13030644.
9
Exploring the Role of Metabolic Hyperferritinaemia (MHF) in Steatotic Liver Disease (SLD) and Hepatocellular Carcinoma (HCC).探索代谢性高铁蛋白血症(MHF)在脂肪性肝病(SLD)和肝细胞癌(HCC)中的作用。
Cancers (Basel). 2025 Feb 28;17(5):842. doi: 10.3390/cancers17050842.
10
Yunnan medicine Jiangzhi ointment alleviates hyperlipid-induced hepatocyte ferroptosis by activating AMPK and promoting autophagy.云南医药降脂膏通过激活AMPK和促进自噬减轻高脂血症诱导的肝细胞铁死亡。
Cytotechnology. 2025 Apr;77(2):73. doi: 10.1007/s10616-025-00737-3. Epub 2025 Mar 5.
非酒精性脂肪性肝病/脂肪性肝炎(NAFL/NASH)中的靶向治疗和新型信号通路。
Signal Transduct Target Ther. 2022 Aug 13;7(1):287. doi: 10.1038/s41392-022-01119-3.
4
Iron Absorption: Factors, Limitations, and Improvement Methods.铁的吸收:影响因素、限制及改善方法。
ACS Omega. 2022 Jun 10;7(24):20441-20456. doi: 10.1021/acsomega.2c01833. eCollection 2022 Jun 21.
5
Ferroptosis in Chronic Liver Diseases: Opportunities and Challenges.慢性肝病中的铁死亡:机遇与挑战
Front Mol Biosci. 2022 Jun 3;9:928321. doi: 10.3389/fmolb.2022.928321. eCollection 2022.
6
Targeting Mitochondrial ROS-Mediated Ferroptosis by Quercetin Alleviates High-Fat Diet-Induced Hepatic Lipotoxicity.槲皮素靶向线粒体活性氧介导的铁死亡减轻高脂饮食诱导的肝脏脂毒性
Front Pharmacol. 2022 Apr 12;13:876550. doi: 10.3389/fphar.2022.876550. eCollection 2022.
7
Contribution of classification based on ferroptosis-related genes to the heterogeneity of MAFLD.基于铁死亡相关基因的分类对 MAFLD 异质性的贡献。
BMC Gastroenterol. 2022 Feb 10;22(1):55. doi: 10.1186/s12876-022-02137-9.
8
The multifaceted role of ferroptosis in liver disease.铁死亡在肝脏疾病中的多方面作用。
Cell Death Differ. 2022 Mar;29(3):467-480. doi: 10.1038/s41418-022-00941-0. Epub 2022 Jan 24.
9
Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?铁死亡与代谢相关脂肪性肝病:有关联吗?
Liver Int. 2022 Jul;42(7):1496-1502. doi: 10.1111/liv.15163. Epub 2022 Jan 23.
10
Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies.铁死亡在非酒精性脂肪性肝病中的作用及其对治疗策略的启示
Biomedicines. 2021 Nov 10;9(11):1660. doi: 10.3390/biomedicines9111660.